Alltemp’s Digital Ad Firm Acquisition Scheduled for September Closing

Written by Customer Service on August 30, 2021. Posted in Mergers And Acquisitions.

WESTLAKE VILLAGE, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) — Alltemp, Inc. (“Alltemp” or “the Company”) (OTCPK: LTMP) announces that the Company’s previously announced definitive letter of intent to acquire an established digital advertising and marketing business, Digi Messaging & Advertising, Inc. (“Digi”) through a share exchange agreement, is now scheduled to be effective September 2021. About Digi Messaging & Advertising, Inc. Digi Messaging & Advertising, Inc. is a digital marketing and advertising company which currently operates multiple service platforms, including SMS, push notification, short links, email and more. Digi is currently building a consumer facing digital marketing and communications platform-as-a-service to allow enterprises, both large and small, to leverage big data to micro-target customers...

Operational Highlights and Financial Results for the Year Ended June 30, 2021

Written by Customer Service on August 30, 2021. Posted in Earnings Releases And Operating Results.

NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reported operational highlights and financial results for the fourth quarter and full-year ended June 30, 2021 (FY2021). “During this calendar year we made significant progress in both regulatory and clinical outcomes for our lead product candidate, remestemcel-L, after experiencing a disappointing set-back last year” said Silviu Itescu, Chief Executive of Mesoblast. “We are pleased with recent recommendations by FDA’s CBER to meet with the review team and address remaining CMC items for remestemcel-L in the treatment of steroid-refractory acute graft versus host disease in children. Additionally, our most recent meeting with the FDA has provided clarity on the pathway...

Madison Pacific Properties Inc. Announces Acquisition of Investment Property

Written by Customer Service on August 30, 2021. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, Aug. 30, 2021 (GLOBE NEWSWIRE) — Madison Pacific Properties Inc. (the Company) (TSX: MPC and MPC.C), a Vancouver-based real estate company, announces that it has agreed to acquire the remaining 50% interest it currently does not hold in a property located at 8155 North Fraser Way, Burnaby, BC from an operating company controlled by Madison Venture Corporation, a significant shareholder. The property is an industrial property consisting of approximately 44,150 square feet of leasable area located on a 1.88 acre site and is currently 100% leased. The 50% interest in the property is being acquired for a purchase price of $7.735 million. Payment for the property, subject to approval of the Toronto Stock Exchange, includes the issuance of 99,928 Class B voting common shares (“Class B Shares”) and 792,046...

Junshi Biosciences Announces 2021 Interim Financial Results and Provides Corporate Updates

Written by Customer Service on August 30, 2021. Posted in Earnings Releases And Operating Results.

SHANGHAI, China, Aug. 31, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the six months ended June 30, 2021 and provided corporate updates. First Half 2021 Financial Highlights Total revenue reached RMB 2,114 million in the first half of 2021, representing an increase of 268% compared to the corresponding period of 2020. The increase was mainly due to the growth of revenue from out-licensing income. Total research and development (“R&D”) expenses were RMB 947 million in the first half of 2021, representing an increase of 34% compared to the corresponding period of 2020. The increase in R&D expenses was mainly due to increased...

Atrion Corporation Announces Election of New Director

Written by Customer Service on August 30, 2021. Posted in Public Companies.

ALLEN, Texas, Aug. 30, 2021 (GLOBE NEWSWIRE) — Atrion Corporation (NASDAQ: ATRI) today announced the election of Maria Sainz as a director, effective immediately. Ms. Sainz brings to our Board over 20 years of medical device and management experience from both Silicon Valley start-ups and large medical device companies. During the period from 2008 until early this year, she served as the CEO of three innovative medtech start-ups. One of these companies was acquired by CooperSurgical in 2021 and another was acquired by Stryker Corporation in 2011. At Stryker, she led the Business Unit that comprised her former company. From 1998 to 2006, Ms. Sainz held a number of leadership positions at Guidant Corporation, including President of the Cardiac Surgery division, Vice President, Global Marketing for the Vascular Intervention division,...

Inspire Medical Systems, Inc. Announces Recommendation by Medicare Panel to Increase Payments for Inspire Therapy to Ambulatory Surgical Centers

Written by Customer Service on August 30, 2021. Posted in Public Companies.

MINNEAPOLIS, Aug. 30, 2021 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that a Centers for Medicare and Medicaid Services (CMS) panel has unanimously approved a recommendation to increase the previously proposed reimbursement for Inspire procedure performed in Ambulatory Surgical Centers (ASCs) as indicated on the CMS website as posted today. Following U.S. Food and Drug Administration approval in 2014, reimbursement for Inspire therapy was determined by the American Medical Association’s (AMA) Current Procedural Technology (CPT) code panel, which concluded in 2016 that the procedure should be conducted under CPT code...

Fountain Asset Corp. Announces its Financial Results for the Quarter Ended June 30, 2021

Written by Customer Service on August 30, 2021. Posted in Earnings Releases And Operating Results.

TORONTO, Aug. 30, 2021 (GLOBE NEWSWIRE) — Fountain Asset Corp. (TSXV:FA) (“Fountain” or the “Company”) would like to announce its financial results for the three months ended June 30, 2021 (“Q2/21”). “The Company posted a small return on Shareholders’ Equity quarter over quarter during Q2/21 as the small cap space came under pressure after a strong start to the year. Fountain has posted a solid first half of the year with Shareholders’ Equity growing by 28%. During the quarter, we continued to see some of our private holdings come public, including Gage Growth Corp. We continue to believe we offer a strong value proposition for our investors by giving them a vehicle to access investments that they would otherwise not have access to,” said Andrew Parks, CEO of Fountain. Highlights from the three months ended June 30, 2021: Adjusted...

Atrion Corporation Increases Quarterly Cash Dividend by 11%

Written by Customer Service on August 30, 2021. Posted in Dividend Reports And Estimates.

ALLEN, Texas, Aug. 30, 2021 (GLOBE NEWSWIRE) — Atrion Corporation (Nasdaq ATRI) today announced an increase in its quarterly cash dividend from $1.75 per share to $1.95 per share. Specifically, the Board of Directors declared a quarterly dividend of $1.95 per share on its outstanding shares of Common Stock. This dividend will be payable on September 30, 2021 to stockholders of record at the close of business on September 15, 2021. Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com. Contact: Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800

Theralase Releases Q221 Unaudited Financial Statements and Quarterly Newsletter

Written by Customer Service on August 30, 2021. Posted in Earnings Releases And Operating Results.

Study II Clinical Data (Preliminary)* Study II Clinical Data (Preliminary)* TORONTO, Aug. 30, 2021 (GLOBE NEWSWIRE) — Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), A clinical stage pharmaceutical company dedicated to the research and development of light activated compounds and their associated drug formulations with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses has released the Company’s unaudited Q22021 condensed interim consolidated financial statements and Quarterly Newsletter (“Newsletter”) which provides updates on the previous quarter and progress on the Phase II Non-Muscle Invasive Bladder Cancer (“NMIBC“) Clinical Study (“Study II”). The Financial Statements can be found on the Company’s...

Captor Capital Releases Unaudited Condensed Interim Consolidated Financial Statements For Quarter Ended June 30, 2021

Written by Customer Service on August 30, 2021. Posted in Public Companies.

Revenues up 80 per cent and Gross Profits up 64 per cent vs. June 2020 TORONTO, Aug. 30, 2021 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMVA; STUTTGART: NMVA), (“Captor” or the “Company”), is pleased to announce today the release of its Unaudited Condensed Interim Consolidated Financial Statements and MD&A for the three months ended June 30, 2021. In the quarter, revenues from the sale of cannabis at the Company’s California dispensary network were $6,769,946, with the Company recording a gross profit of $2,055,798. Revenues from cannabis sales were up $3,002,095 (80 per cent) from the previous financial quarter, while gross profit was up $804,462 (64 per cent). Management Commentary “We have seen significant growth quarter-over-quarter, as Captor continues to benefit from the geographic...

Day: August 30, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice